Skip to Main Content
research
patients
Covid-19
Reporting from the frontiers of health and medicine
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
The Readout
STAT+

Cell and gene therapies could be a safer bet than other drugs

  • Damian Garde

By Damian Garde Oct. 12, 2023

Reprints
stem cells from bone marrow
David J. Phillip/AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning, everyone. Damian here with data on biotech’s belt-tightening, the advance of xenotransplantation, and the escalating Ozempic panic.

advertisement

The need-to-know this morning

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

About the Author Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Tags

Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!

To submit a correction request, please visit our Contact Us page.

Serotonin levels are depleted in long Covid patients, study…
Serotonin levels are depleted in long Covid patients, study says, pointing to a potential cause for…
FDA’s warning to J&J’s Abiomed signals a crackdown on…
FDA’s warning to J&J’s Abiomed signals a crackdown on digital health tools
Is there a nursing shortage in the United States?…
Is there a nursing shortage in the United States? Depends on who you ask
Our expensive obesity drugs are worth it, Novo Nordisk…
Our expensive obesity drugs are worth it, Novo Nordisk and Eli Lilly argue in raft of…
How one scientist’s determination made Novo Nordisk an obesity-drug…
How one scientist’s determination made Novo Nordisk an obesity-drug powerhouse
Studies highlight risks of excluding people with obesity from…
Studies highlight risks of excluding people with obesity from drug trials

Recommended Stories